Table 2

Mean unadjusted and deseasonalised concentrations of 25-hydroxyvitamin D and vitamin D metabolites (ng/ml) for all patients, and RR-MS versus SP-MS patients

All MS patients (n=193)RR-MS (n=170)SP-MS (n=23)
UnadjustedDeseasonalisedUnadjustedDeseasonalisedCrudeDeseasonalised
25(OH)VD28.8±3.025.1±9.728.7±11.824.9±9.730.2±8.126.8±7.4
25(OH)VD321.1±9.721.1±9.521.0±10.021.1±9.721.5±7.221.3±9.7
25(OH)VD24.03±6.6NA3.82±7.5NA5.49±8.5NA
1, 25(OH)2VD30.029±0.0160.029±0.0720.029±0.0160.029±0.0160.022±0.0160.025±0.016
24, 25(OH)2VD33.74±3.043.75±2.983.82±3.193.83±3.133.17±1.453.12±1.34
  • MS, multiple sclerosis; RR-MS, relapsing–remitting multiple sclerosis; SP-MS, secondary progressive multiple sclerosis.